Effects of systemic fingolimod treatment on anterior segment parameters and tear film functions
Systemic use of fingolimod may increase Schirmer I test and TBUT values in MS patients without altering other anterior segment parameters within 6 months.
Authors
- Atike Burcin Tefon Aribas (ORCID: https://orcid.org/0000-0002-5248-9747)
- Gönül Vural (ORCID: https://orcid.org/0000-0002-1245-7273)
- Semra Mungan (ORCID: https://orcid.org/0000-0002-6469-5185)
- Ersin Kasım Ulusoy (ORCID: https://orcid.org/0000-0001-7003-4597)
- Nilay Yüksel (ORCID: https://orcid.org/0000-0003-4336-7438)
- Feyza Dicle Işık (ORCID: https://orcid.org/0000-0003-4992-5103)
- Gökhan Çelik
Institutions
- Bilkent University (TR)
- Başkent University Hospital (TR)
- Tarsus University (TR)
- Ankara Bilkent City Hospital (TR)
Publication Details
- Journal
- Cutaneous and Ocular Toxicology
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1080/15569527.2024.2432508
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00